Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and Cardiac Diseases

daunorubicin has been researched along with Cardiac Diseases in 101 studies

Research

Studies (101)

TimeframeStudies, this research(%)All Research%
pre-199053 (52.48)18.7374
1990's9 (8.91)18.2507
2000's26 (25.74)29.6817
2010's11 (10.89)24.3611
2020's2 (1.98)2.80

Authors

AuthorsStudies
Henry, DW; Smith, TH; Tong, GL; Wu, HY1
Adamcová, M; Holečková, M; Jirkovský, E; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Palička, V; Pokorná, Z; Šimůnek, T; Štěrba, M1
Aalikhani, M; Alikhani, M; Bazi, Z; Oladnabi, M; Shamsabadi, F1
Ceckova, M; Hofman, J; Morell, A; Novotna, E; Sorf, A; Staud, F; Wsol, V1
Bourquin, JP; Creutzig, U; Dworzak, MN; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; Reinhardt, D; Ritter, J; Sander, A; Schrauder, A; Starý, J; von Neuhoff, C; von Stackelberg, A; Zimmermann, M1
Adamcová, M; Geršl, V; Hroch, M; Jirkovský, E; Lenčová-Popelová, O; Mazurová, Y; Mičuda, S; Šimůnek, T; Štěrba, M; Vávrová, J1
Liu, Y; Wang, D1
Fang, QJ; He, RL; Lian, JB; Lin, MJ; Wang, RX; Wu, ZJ; Yu, J1
Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L1
Horacek, JM; Jakl, M; Jebavy, L; Pudil, R1
Baubion, N; Buzyn, A; Decaudin, D; Delarue, R; Fourquet, A; Ghez, D; Hermine, O; Messas, E; Rubio, MT; Suarez, F; Varet, B; Willems, L1
Geršl, V; Hašková, P; Jirkovský, E; Mertlíková-Kaiserová, H; Popelová, O; Simůnek, T; Stěrba, M; Vávrová, A1
Aizawa, Y; Arozal, W; Harima, M; Kodama, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K1
Adamcová, M; Brcáková-Dolezelová, E; Cervinková, Z; Gersl, V; Hasková, P; Hroch, M; Jirkovsky, E; Kriváková-Stanková, P; Micuda, S; Popelová, O; Simůnek, T; Sterba, M; Vávrová, A1
Graham, J; Grigliatti, TA; Heffner, D; Hogge, D; Liu, J; Lubieniecka, JM; Reid, R; Riggs, WK1
Burke, BE; Cusack, BJ; Gambliel, HA; Mushlin, PS; Olson, RD; Olson, SJ1
Cusack, BJ; Gabliel, H; Olson, RD; Young, SP1
Bull, C; Dorup, I; Levitt, GA; Sorensen, K; Sullivan, ID1
Rivera, E1
Campos, S1
Safra, T1
Dorup, I; Levitt, GA; Sorensen, K; Sullivan, I1
Charlier, H; Cusack, BJ; Gambliel, H; Hadjokas, N; Musser, B; Olson, RD; Shadle, SE1
Aung, L; Kirk, RC; Liang, S; Quah, TC; Tan, RM; Yeoh, AE1
Adamcová, M; Gersl, V; Kaiserová, H; Mazurová, Y; Ponka, P; Popelová, O; Potácová, A; Simunek, T; Sterba, M2
Adamcová, M; Gersl, V; Holecková, M; Mazurová, Y; Popelová, O; Potácová, A; Simůnek, T; Sterba, M1
Adamcová, M; Gersl, V; Guncová, I; Kaiserová, H; Mazurová, Y; Palicka, V; Ponka, P; Popelová, O; Potácová, A; Simůnek, T; Sterba, M1
Berdel, WE; Brunnberg, U; Büchner, T; Kessler, T; Krug, U; Mesters, RM; Mohr, B; Mohr, M; Müller-Tidow, C; Sauerland, C; Schliemann, C; Serve, H1
Budach, W1
Casamassimi, A; de Nigris, F; Fiorito, C; Napoli, C; Rienzo, M; Schiano, C1
Adamcová, M; Gersl, V; Guncová, I; Hroch, M; Mazurová, Y; Popelová, O; Simůnek, T; Sterba, M1
Bernardini, C; Del Tacca, M; Soldani, G1
Applefeld, MM; Bulkley, BH; Grochow, LB; Mader, LC; Taylor, AL; Wiernik, PH1
Bramwell, V; Bruntsch, U; Cavalli, F; Decoster, G; Dombernowsky, P; Høst, H; Renard, G; Rozencweig, M; ten Bokkel Huinink, W; Van Glabbeke, M1
Deprez-DeCampeneere, D; Jaenke, RS; Trouet, A1
Gahrton, G; Lockner, D; Lönnqvist, B; Paul, C; Peterson, C1
Bozzio, A; Favrot, MC; Philip, T; Philippe, N; Pouyau, G; Souillet, G1
Boiron, M; Gisselbrecht, C; Jacquillat, C; Marty, M; Weil, M1
Björkholm, M; Christenson, I; Engstedt, L; Gahrton, G; Hast, R; Holm, G; Killander, A; Lantz, B; Lockner, D; Lönnqvist, B; Mellstedt, H; Oberg, G; Palmblad, J; Paul, C; Peterson, C; Simonsson, B; Stalfelt, AM; Udén, AM; Wadman, B1
Piccart, M; Rozencweig, M; Von Hoff, DD1
Aust, JC; Comis, RL; Crooke, ST; DiFino, SM; Ginsberg, SJ; Issell, BF; Pittman, K; Poiesz, BJ; Rudolph, A; Tinsley, RW1
Barber, G; Goldwein, JW; Jakacki, RI; Larsen, RL; Silber, JH1
Lundström, U; Pesonen, E; Pihkala, J; Saarinen, UM; Siimes, MA; Virkola, K; Virtanen, K1
Hara, T; Kawaoto, H; Mizuno, Y; Ueda, K1
Besse, P; Bonoron-Adèle, S; Gouverneur, G; Pouna, P; Robert, J; Tariosse, L1
Hortobágyi, GN1
Asai, O; Dobashi, N; Funakoshi, S; Kato, A; Katori, M; Kobayashi, T; Kuraishi, Y; Maki, N; Nagamine, M; Ogawa, M; Ogihara, A; Saito, T; Tajima, N; Takei, Y; Usui, N; Watanabe, H; Yamaguchi, Y; Yamazaki, H; Yano, S1
Lemez, P; Maresová, J1
Foltinova, A; Hulin, I; Mladosievicova, B; Petrasova, H1
Berg, A; Bink-Boelkens, MT; Kamps, WA; Postma, A; Rammeloo, LA; Sobotka-Plojhar, MA; Veerman, AJ1
Ikeno, A; Ishikawa, T; Iuchi, K; Matsuda, T; Nakamura, S; Ohtake, S; Okumura, H; Takamatsu, H; Takeshima, M; Usuda, K; Yoshida, T1
Arrigoni, C; Brughera, M; Della Torre, P; Imondi, AR; Moneta, D; Podestà, A; Sammartini, U; Terron, A1
Adamcová, M; Hrdina, R; Machacková, J; Mazurová, Y; Nobilis, M1
Chilcote, RR; Kadin, ME; Kjeldsberg, C; Krailo, MD; Meadows, AT; Morse, M; Siegel, SE; Sposto, R; Steinherz, PG; Termuhlen, AM1
Dziegiel, P; Jethon, Z; Rabczyński, J; Sopel, M; Suder, E; Surowiak, P; Zabel, M1
Dziegiel, P; Surowiak, P; Zabel, M1
Balazs, T; Ferrans, VJ1
Casirola, G; Invernizzi, R; Ippoliti, G; Marini, G1
Bühner, R1
Acton, EM; Chen, HH; Lown, JW; Plambeck, JA1
Ferrans, VJ1
Cox, PJ; Farmer, PB1
Ardalan, B; Bier, C; Herman, E; Krop, S; Waravdekar, V1
Cheng, CC; Zbinden, G; Zee-Cheng, RK1
Acton, EM; Henry, DW; Tong, GL1
Maral, R1
Kanda, H; Kawai, Y; Murata, K; Suzuki, T; Tominaga, K1
Billingham, ME; Bristow, MR; Daniels, JR; Mason, JW1
Bailey, C; Donaldson, MH; Hutchinson, RJ; Wood, D1
Benjamin, RS; Billingham, ME; Mason, JW1
Hamilton, GW; Kennedy, JW; Narahara, KA; Ritchie, JL; Singer, JW1
Lenaz, L; Page, JA1
Mettler, FP; Ward, JM; Young, DM1
Bier, CC; Jaenke, RS1
Bódis, L; Herr, G; Nagy, L; Patakfalvi, A1
Buja, LM; Ferrans, VJ; Maron, BJ1
Gilladoga, AC; Manuel, C; Murphy, ML; Sternberg, SS; Tan, CT; Wollner, N1
Weiss, RB1
Hůla, J; Slechtová, J; Svojgrová, M1
Sazuka, Y; Takino, Y; Tanizawa, H1
Alekseev, NA; Zil'berman, MV1
Corbo, S; De Santis, F; Loperfido, F; Pennestrì, F; Vigna, C1
Cox, G; Gillies, H; Harper, P; Johnson, S; Liang, R; Parapia, L; Rogers, H1
Arlin, Z; Büchner, T; Donhuijsen-Ant, R; Hiddemann, W; Kreutzmann, H; Lengfelder, E; Ludwig, WD; Mertelsmann, R; Straif, K1
Biron, P; Bouffet, E; Brunat-Mentigny, M; Favrot, MC; Philip, T; Pinkerton, R1
Adam, WE; Bitter, F; Delagardelle, C; Henze, E; Stauch, M; Tymiec, A1
Angelucci, E; Baronciani, D; Giardini, C; Luccarelli, G; Nicolini, G1
Akoun, G; Blanchon, F; Chatelet, F; Colbert, N; Herman, D; Izrael, V; Milleron, B; Roland, J; Schlienger, M; Vannetzel, JM1
Benjamin, RS; Chawla, SP; Legha, SS1
Bachur, NR; Hildebrand, RC; Jaenke, RS1
Böhnel, J; Höcker, P; Stacher, A1
Henderson, ES; Lippman, M; Zager, R1
Auclerc, G; Bernard, J; Boiron, M; Bussel, A; Delobel, J; Dresch, C; Flandrin, G; Gemon, MF; Izrael, V; Jacquillat, C; Loisel, JP; Najean, Y; Rain, D; Schaison, G; Seligmann, M; Tanzer, J; Weil, M; Weisgerber, C1
Barboni, F; Pannuti, F1
Desbuquois, G; Julienne, O; Laine, JL; Lamagnère, JP; Laugier, J; Leroy, J1
Cunescu, V; Pârvu, V1
Herman, EH; Vick, JA1

Reviews

10 review(s) available for daunorubicin and Cardiac Diseases

ArticleYear
Liposomal anthracyclines in metastatic breast cancer: clinical update.
    The oncologist, 2003, Volume: 8 Suppl 2

    Topics: Anthracyclines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Daunorubicin; Doxorubicin; Heart Diseases; Humans; Liposomes; Neoplasm Metastasis; Paclitaxel

2003
Liposomal anthracyclines: adjuvant and neoadjuvant therapy for breast cancer.
    The oncologist, 2003, Volume: 8 Suppl 2

    Topics: Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Daunorubicin; Doxorubicin; Heart Diseases; Humans; Liposomes; Nausea; Neoadjuvant Therapy; Risk Factors

2003
Cardiac safety of liposomal anthracyclines.
    The oncologist, 2003, Volume: 8 Suppl 2

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Heart Diseases; Humans; Liposomes; Risk Factors

2003
Anthracyclines in the treatment of cancer. An overview.
    Drugs, 1997, Volume: 54 Suppl 4

    Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Heart Diseases; Humans; Leukemia; Neoplasms; Neutropenia; Stomatitis

1997
Cardiac lesions induced by chemicals.
    Environmental health perspectives, 1978, Volume: 26

    Topics: Acute Disease; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Cardiomyopathies; Cardiovascular System; Chronic Disease; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Heart Diseases; Humans; Species Specificity

1978
Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
    Cancer treatment reports, 1978, Volume: 62, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Biopsy; Daunorubicin; Doxorubicin; Heart Diseases; Humans; Microscopy, Electron; Myocardium; Time Factors

1978
Towards selectivity? Approaches to the design of new anti-tumour agents--II.
    Cancer treatment reviews, 1977, Volume: 4, Issue:2

    Topics: Altretamine; Amino Acids; Antineoplastic Agents; Carbohydrates; Chelating Agents; Colchicine; Coloring Agents; Dacarbazine; Daunorubicin; Doxorubicin; Drug Interactions; Ellipticines; Folic Acid Antagonists; Heart Diseases; Humans; Lectins; Neoplasms; Nitrosourea Compounds; Peptide Hydrolases; Podophyllotoxin; Polymers; Structure-Activity Relationship

1977
Myofibrillar abnormalities following cardiac muscle cell injury.
    Recent advances in studies on cardiac structure and metabolism, 1975, Volume: 6

    Topics: Cardiomyopathies; Coronary Disease; Daunorubicin; Doxorubicin; Female; Heart Diseases; Humans; Male; Myocardial Infarction; Myocardium; Myofibrils; Necrosis

1975
The anthracyclines: will we ever find a better doxorubicin?
    Seminars in oncology, 1992, Volume: 19, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Chemistry, Pharmaceutical; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Drugs, Investigational; Heart Diseases; Humans; Neoplasms

1992
[Drug iatrogenesis in cardiology].
    Medicina interna, 1971, Volume: 23, Issue:1

    Topics: Antidepressive Agents; Antihypertensive Agents; Appetite Depressants; Blood Coagulation Disorders; Cardiovascular Diseases; Contraceptives, Oral; Coronary Disease; Daunorubicin; Dihydroxyphenylalanine; Heart Diseases; Humans; Iatrogenic Disease; Imipramine; Monoamine Oxidase Inhibitors; Phenothiazines; Shock, Cardiogenic; Transfusion Reaction; Vitamin K

1971

Trials

11 trial(s) available for daunorubicin and Cardiac Diseases

ArticleYear
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.
    Blood, 2013, Jul-04, Volume: 122, Issue:1

    Topics: Adolescent; Antibiotics, Antineoplastic; Bone Marrow; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Idarubicin; Leukemia, Myeloid, Acute; Liposomes; Male; Multivariate Analysis; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Risk Factors; Treatment Outcome

2013
Does anthracycline administration by infusion in children affect late cardiotoxicity?
    British journal of haematology, 2004, Volume: 124, Issue:4

    Topics: Adolescent; Antibiotics, Antineoplastic; Child; Daunorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Heart Diseases; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ventricular Function, Left

2004
Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.
    Leukemia research, 2008, Volume: 32, Issue:3

    Topics: Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Matched-Pair Analysis; Middle Aged; Thioguanine

2008
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:4

    Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carubicin; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Metastasis; Random Allocation; Vomiting

1984
Daunorubicin (Cerubidine).
    The Medical letter on drugs and therapeutics, 1980, Apr-18, Volume: 22, Issue:8

    Topics: Bone Marrow; Clinical Trials as Topic; Daunorubicin; Heart Diseases; Humans; Leukemia

1980
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.
    Cancer chemotherapy and pharmacology, 1981, Volume: 6, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aging; Antibiotics, Antineoplastic; Bone Marrow Diseases; Clinical Trials as Topic; Daunorubicin; DNA; DNA Adducts; Female; Heart Diseases; Humans; Immunotherapy; Leukemia; Male; Middle Aged

1981
Role of daunorubicin in the induction therapy for adult acute myeloid leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome

1998
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.
    Seminars in oncology, 1998, Volume: 25, Issue:4 Suppl 10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Daunorubicin; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Razoxane

1998
Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Administration Schedule; Echocardiography; Electrocardiography; Female; Heart Diseases; Heart Rate; Humans; Male; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survivors

2000
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
    Medical and pediatric oncology, 2001, Volume: 37, Issue:5

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Prednisone; Recurrence; Stomatitis; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine

2001
A prospective study of detorubicin in malignant mesothelioma.
    Cancer, 1985, Nov-01, Volume: 56, Issue:9

    Topics: Adult; Aged; Alopecia; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Female; Heart Diseases; Humans; Male; Mesothelioma; Middle Aged; Nausea; Peritoneal Neoplasms; Pleural Neoplasms; Prospective Studies; Vomiting

1985

Other Studies

80 other study(ies) available for daunorubicin and Cardiac Diseases

ArticleYear
Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity.
    Journal of medicinal chemistry, 1979, Volume: 22, Issue:8

    Topics: Alkylation; Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; DNA; Doxorubicin; Heart Diseases; Mice; Mutagens; Rats

1979
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up.
    Clinical science (London, England : 1979), 2022, 01-14, Volume: 136, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Daunorubicin; Heart Diseases; Heart Failure; Male; Perindopril; Rabbits; Troponin T

2022
In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques.
    Biochemical and biophysical research communications, 2021, 10-01, Volume: 572

    Topics: Aminoisobutyric Acids; Aminopterin; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Daunorubicin; Digoxin; Drug Repositioning; Gene Expression; Heart Diseases; Humans; Lactams, Macrocyclic; Leucine; Ligands; Methylergonovine; Molecular Docking Simulation; Morpholines; Proline; Quinoxalines; Sulfonamides

2021
Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters.
    Biochemical pharmacology, 2019, Volume: 163

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Binding Sites; Cell Line, Tumor; Cell Proliferation; Cloning, Molecular; Daunorubicin; Dogs; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Heart Diseases; Humans; Imidazoles; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Protein Binding; Pyrimidines

2019
Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
    Toxicology, 2013, Sep-15, Volume: 311, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Citrate (si)-Synthase; Daunorubicin; Heart Diseases; Male; NF-E2-Related Factor 2; Oxidative Stress; Rabbits; Razoxane; Troponin T; Ventricular Function, Left

2013
Administration of chromium(III) and manganese(II) as a potential protective approach against daunorubicin-induced cardiotoxicity: in vitro and in vivo experimental evidence.
    Biological trace element research, 2013, Volume: 156, Issue:1-3

    Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxins; Chromium; Daunorubicin; Dose-Response Relationship, Drug; Heart Diseases; Male; Manganese; Mice; Myocardium

2013
Sodium ferulate protects against daunorubicin-induced cardiotoxicity by inhibition of mitochondrial apoptosis in juvenile rats.
    Journal of cardiovascular pharmacology, 2014, Volume: 63, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Coumaric Acids; Daunorubicin; Heart Diseases; Hemodynamics; Male; Mitochondria; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley

2014
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
    Toxicology, 2016, Nov-30, Volume: 372

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Chronic Disease; Daunorubicin; Doxorubicin; Heart Diseases; Heart Failure; Lipid Peroxidation; Molsidomine; Nitric Oxide Donors; Oxidative Stress; Rabbits; Reactive Oxygen Species; Ventricular Remodeling

2016
Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
    Leukemia research, 2009, Volume: 33, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxins; Cytarabine; Daunorubicin; Electrocardiography; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Monitoring, Physiologic

2009
[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer].
    Bulletin du cancer, 2010, Volume: 97, Issue:2

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Daunorubicin; Epirubicin; Female; Fluorouracil; Heart Diseases; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Middle Aged; Neoplasms, Second Primary; Remission Induction; Stroke Volume

2010
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.
    Archives of toxicology, 2011, Volume: 85, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Buthionine Sulfoximine; Cell Line; Daunorubicin; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Heart; Heart Diseases; Hydrogen Peroxide; Male; Models, Animal; Oxidative Stress; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Thiazolidines

2011
Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Benzoates; Daunorubicin; Doxorubicin; Heart; Heart Diseases; Male; Malondialdehyde; Matrix Metalloproteinase 2; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Telmisartan; Ventricular Function, Left

2010
Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:2

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Nucleus; Daunorubicin; Echocardiography; Glutathione; Heart Diseases; Heart Function Tests; Heart Ventricles; Lipid Peroxidation; Male; Mitochondria, Heart; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Rabbits; Real-Time Polymerase Chain Reaction; Survival; Transcription Factors; Troponin T

2012
Single-nucleotide polymorphisms in aldo-keto and carbonyl reductase genes are not associated with acute cardiotoxicity after daunorubicin chemotherapy.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012, Volume: 21, Issue:11

    Topics: Adolescent; Adult; Aged; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Daunorubicin; Female; Heart Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Young Adult

2012
Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.
    Cardiovascular toxicology, 2002, Volume: 2, Issue:1

    Topics: Aging; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Caffeine; Daunorubicin; Doxorubicin; Female; Heart Atria; Heart Diseases; Male; Muscle Relaxation; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Rabbits; Sarcoplasmic Reticulum

2002
Effect of aging on cardiac contractility in a rat model of chronic daunorubicin cardiotoxicity.
    Cardiovascular toxicology, 2002, Volume: 2, Issue:2

    Topics: Aging; Animals; Antibiotics, Antineoplastic; Calcium Channels; Cholesterol; Chronic Disease; Creatinine; Daunorubicin; Depression, Chemical; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Rats; Rats, Inbred F344; Sarcoplasmic Reticulum; Time Factors; Triglycerides; Ventricular Function, Left

2002
Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study.
    Cancer, 2003, Apr-15, Volume: 97, Issue:8

    Topics: Antibiotics, Antineoplastic; Child, Preschool; Cohort Studies; Daunorubicin; Echocardiography; Female; Heart; Heart Diseases; Humans; Kidney Neoplasms; Longitudinal Studies; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Wilms Tumor

2003
Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Chelating Agents; Daunorubicin; Heart Diseases; Iron Regulatory Protein 1; Iron-Regulatory Proteins; Male; Rats; Rats, Inbred F344; Razoxane

2006
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Acute Disease; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Daunorubicin; Developing Countries; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Infant; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Prednisone; Remission Induction; Retrospective Studies; Singapore; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine

2007
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Blood Pressure; Body Weight; Cardiac Output; Cardiotonic Agents; Cell Division; Chinchilla; Daunorubicin; Electrocardiography; Heart Diseases; Heart Rate; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Myocardium; Pyridoxal; Rabbits; Stroke Volume; Troponin T; Ventricular Function, Left

2006
Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination.
    Physiological research, 2007, Volume: 56, Issue:5

    Topics: Anesthetics; Animals; Antibiotics, Antineoplastic; Biomarkers; Blood Pressure; Calcium; Collagen; Daunorubicin; Disease Models, Animal; Echocardiography, Doppler; Heart Diseases; Heart Rate; Male; Myocardial Contraction; Myocardium; Pilot Projects; Rabbits; Time Factors; Troponin T; Ventricular Function, Left; Ventricular Pressure; Xylazine

2007
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
    Toxicology, 2007, Jun-25, Volume: 235, Issue:3

    Topics: Aldehydes; Animals; Cells, Cultured; Daunorubicin; Heart Diseases; Heart Ventricles; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Myocytes, Cardiac; Rabbits; Rats; Troponin T

2007
Cardiac risks in multimodal breast cancer treatment.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2007, Volume: 183 Spec No 2

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Daunorubicin; Female; Follow-Up Studies; Heart; Heart Diseases; Humans; Meta-Analysis as Topic; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk; Time Factors; Trastuzumab

2007
Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:3

    Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antibiotics, Antineoplastic; Benzopyrans; Carbazoles; Carvedilol; Daunorubicin; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Ethanolamines; Glutathione; Heart Diseases; Male; Nebivolol; Nitrates; Oxidative Stress; Propanolamines; Rats; Rats, Sprague-Dawley

2008
Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity.
    Hemoglobin, 2008, Volume: 32, Issue:1-2

    Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Daunorubicin; Heart Diseases; Iron Chelating Agents; Isoniazid; Pyridoxal; Rabbits

2008
Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1

    Topics: Animals; Anthracyclines; Antineoplastic Agents; Cardiotonic Agents; Cell Proliferation; Daunorubicin; Deferiprone; Heart Diseases; HL-60 Cells; Humans; Male; Pyridones; Rabbits

2008
Noradrenaline and alpha blockers in daunomycin cardiotoxicity.
    Clinical toxicology, 1981, Volume: 18, Issue:12

    Topics: Adrenergic alpha-Antagonists; Animals; Daunorubicin; Electrocardiography; Female; Guinea Pigs; Heart Diseases; Male; Myocardium; Nicergoline; Norepinephrine; Yohimbine

1981
Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
    Cancer, 1984, Apr-15, Volume: 53, Issue:8

    Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cell Nucleus; Chemotherapy, Cancer, Regional Perfusion; Cytoplasm; Daunorubicin; Heart; Heart Diseases; Myocardium; Naphthacenes; Rabbits; Time Factors

1984
Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Cancer research, 1980, Volume: 40, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorometry; Glycosides; Heart Diseases; Heart Failure; Injections, Intravenous; Kinetics; Myocardium; Naphthacenes; Rabbits

1980
Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three cases.
    Cancer, 1981, Oct-01, Volume: 48, Issue:7

    Topics: Adult; Antibiotics, Antineoplastic; Daunorubicin; DNA; DNA Adducts; Doxorubicin; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes

1981
[Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Pediatrie, 1981, Volume: 36, Issue:6

    Topics: Adolescent; Antibiotics, Antineoplastic; Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Heart Diseases; Humans; Naphthacenes

1981
Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Cancer treatment reports, 1981, Volume: 65 Suppl 4

    Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Bone Marrow; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Heart Diseases; Humans; Leukemia; Middle Aged; Naphthacenes

1981
The cardiotoxicity of anticancer agents.
    Seminars in oncology, 1982, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Heart; Heart Diseases; Heart Failure; Humans; Neoplasms

1982
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States.
    Cancer research, 1982, Volume: 42, Issue:7

    Topics: Adult; Aged; Agranulocytosis; Carubicin; Colony-Forming Units Assay; Daunorubicin; Drug Evaluation; Female; Heart Diseases; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms

1982
Increased risk of cardiac dysfunction after anthracyclines in girls.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:7

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Daunorubicin; Doxorubicin; Electrocardiography; Exercise Test; Female; Gated Blood-Pool Imaging; Heart Diseases; Humans; Male; Sex Factors

1993
Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Doxorubicin; Female; Follow-Up Studies; Heart; Heart Diseases; Humans; Male; Neoplasms; Radiation Injuries; Radiotherapy

1996
Attenuation of cardiotoxicity of daunomycin using a complex with heparin.
    International journal of hematology, 1996, Volume: 63, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Heart Diseases; Heparin; Male; Mesocricetus; Mice; Tumor Cells, Cultured

1996
Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    British journal of pharmacology, 1996, Volume: 117, Issue:7

    Topics: Animals; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Daunorubicin; Drug Evaluation, Preclinical; Heart; Heart Diseases; In Vitro Techniques; Liposomes; Male; Myocardium; Rats; Rats, Sprague-Dawley; Razoxane; Ventricular Function, Left; Ventricular Pressure

1996
Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters.
    International journal of molecular medicine, 2000, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Disease-Free Survival; Doxorubicin; Electrocardiography; Female; Heart; Heart Diseases; Humans; Male; Neoplasms

2000
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
    Acta haematologica, 2000, Volume: 104, Issue:4

    Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Biomarkers; Cardiac Output, Low; Daunorubicin; Female; Heart Diseases; Heart Failure; Heart Function Tests; Humans; Leukemia; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric

2000
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Bone Marrow Diseases; Daunorubicin; Doxorubicin; Female; Heart Diseases; Leukocyte Count; Male; Organ Size; Rats; Rats, Sprague-Dawley

2001
Evaluation of cardiac effects of the new antineoplastic drug --dimethoxybenfluron--in the rabbit.
    Physiological research, 2001, Volume: 50, Issue:5

    Topics: Animals; Antineoplastic Agents; Daunorubicin; Fluorenes; Heart; Heart Diseases; Hemodynamics; Myocardium; Rabbits; Troponin T

2001
Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2002, Volume: 53, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Daunorubicin; Doxorubicin; Drug Interactions; Heart Diseases; Heart Ventricles; Injections, Intravenous; Injections, Subcutaneous; Lipid Peroxidation; Male; Melatonin; Myocardium; Oxidative Stress; Rats; Rats, Inbred BUF

2002
Correlation of histopathological and biochemical appraisal of anthracyclin-induced myocardium damage.
    Folia histochemica et cytobiologica, 2002, Volume: 40, Issue:2

    Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Heart Diseases; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Rats; Rats, Inbred BUF

2002
Letter: Daunorubicin cardiotoxicity.
    Lancet (London, England), 1976, Feb-21, Volume: 1, Issue:7956

    Topics: Aged; Daunorubicin; Heart; Heart Diseases; Humans; Male; Middle Aged

1976
[Cardiotoxicity of cytostatics in long-term therapy].
    Deutsche medizinische Wochenschrift (1946), 1978, Aug-18, Volume: 103, Issue:33

    Topics: Daunorubicin; Doxorubicin; Heart Diseases; Humans; Long-Term Care

1978
Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.
    Biochemical pharmacology, 1979, Sep-01, Volume: 28, Issue:17

    Topics: Chemical Phenomena; Chemistry; Daunorubicin; DNA, Neoplasm; Drug Stability; Heart Diseases; Hydrogen Peroxide; Oxygen; Superoxides; Time Factors

1979
Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters.
    Cancer treatment reports, 1979, Volume: 63, Issue:1

    Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Cricetinae; Daunorubicin; Heart Diseases; Liver; Liver Diseases; Male; Mesocricetus; Myocardium; Piperazines; Rats; Razoxane; Stereoisomerism; Time Factors

1979
Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics.
    Journal of pharmaceutical sciences, 1979, Volume: 68, Issue:3

    Topics: Animals; Anthracenes; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Daunorubicin; Doxorubicin; Heart Diseases; Mice; Neoplasms, Experimental; Rats

1979
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
    Journal of medicinal chemistry, 1979, Volume: 22, Issue:1

    Topics: Animals; Daunorubicin; DNA; DNA, Neoplasm; Heart Diseases; Leukemia L1210; Mice; Mutagens; Neoplasm Transplantation; Neoplasms, Experimental; Rats; RNA, Neoplasm

1979
Biological activities of rubidazone.
    Cancer chemotherapy and pharmacology, 1979, Volume: 2, Issue:1

    Topics: Animals; Antineoplastic Agents; Daunorubicin; DNA; Heart Diseases; Immunosuppressive Agents; Lethal Dose 50; Mice; Mutagens; Neoplasms, Experimental; RNA

1979
Cardiotoxicity of anthracycline antineoplastic drugs--Clinicopathological and experimental studies.
    Japanese circulation journal, 1979, Volume: 43, Issue:11

    Topics: Adolescent; Adult; Aged; Animals; Child; Daunorubicin; Doxorubicin; Electrocardiography; Electrolytes; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardium; Rabbits; Water

1979
Clinical spectrum of anthracycline antibiotic cardiotoxicity.
    Cancer treatment reports, 1978, Volume: 62, Issue:6

    Topics: Adolescent; Aged; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Time Factors

1978
Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Cancer treatment reports, 1978, Volume: 62, Issue:6

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Carotid Arteries; Child; Child, Preschool; Daunorubicin; Doxorubicin; Electrocardiography; Evaluation Studies as Topic; Heart Diseases; Heart Failure; Heart Rate; Humans; Monitoring, Physiologic; Phonocardiography; Pulse

1978
Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Cancer treatment reports, 1978, Volume: 62, Issue:6

    Topics: Biopsy; Daunorubicin; DNA; Doxorubicin; Electrocardiography; Endocardium; Heart Diseases; Heart Failure; Humans; Myocardium

1978
Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy.
    Cancer treatment reports, 1978, Volume: 62, Issue:6

    Topics: Adult; Aged; Angiography; Antibiotics, Antineoplastic; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Time Factors

1978
Cardiotoxicity of adriamycin and related anthracyclines.
    Cancer treatment reviews, 1976, Volume: 3, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Chick Embryo; Cricetinae; Daunorubicin; Dogs; Doxorubicin; Haplorhini; Heart; Heart Conduction System; Heart Diseases; Heart Failure; Humans; Myocardium; Rabbits

1976
Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Cancer research, 1977, Volume: 37, Issue:8 Pt 1

    Topics: Animals; Bone and Bones; Cecum; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Heart Diseases; Heart Failure; Intestine, Small; Kidney; Liver; Male; Myocardium; Rats; Sarcoplasmic Reticulum; Time Factors

1977
Function of myocardial mitochondria in the adriamycin-induced cardiomyopathy of rabbits.
    Journal of the National Cancer Institute, 1976, Volume: 57, Issue:5

    Topics: Adenosine Diphosphate; Animals; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart Diseases; Male; Mitochondria, Muscle; Myocardium; Oxygen Consumption; Rabbits; Time Factors

1976
[Possibility for the prevention of cardio toxic effect of Cerubidin].
    Orvosi hetilap, 1975, Aug-24, Volume: 116, Issue:34

    Topics: Daunorubicin; Digoxin; Heart; Heart Diseases; Humans; Leukemia, Myeloid, Acute

1975
The cardiotoxicity of adriamycin and daunomycin in children.
    Cancer, 1976, Volume: 37, Issue:2 Suppl

    Topics: Adolescent; Child; Daunorubicin; Digitalis Glycosides; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Heart Diseases; Heart Failure; Humans; Neoplasms

1976
[Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Vnitrni lekarstvi, 1991, Volume: 37, Issue:2

    Topics: Daunorubicin; Doxorubicin; Electrocardiography; Heart; Heart Diseases; Heart Rate; Humans; Leukemia; Lymphoma

1991
Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity.
    Japanese journal of cancer research : Gann, 1989, Volume: 80, Issue:10

    Topics: Aclarubicin; Animals; Carcinoma, Ehrlich Tumor; Daunorubicin; DNA; Doxorubicin; Glutathione Peroxidase; Heart Diseases; Kidney; Lipid Peroxidation; Liver; Lung; Male; Mice; Myocardium; Protein Biosynthesis; RNA

1989
[Diagnosis and treatment of rubomycin-induced heart lesions in children with leukemia].
    Gematologiia i transfuziologiia, 1989, Volume: 34, Issue:9

    Topics: Adolescent; Cardiotonic Agents; Child; Child, Preschool; Daunorubicin; Electrocardiography; Female; Heart Diseases; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ultrasonography

1989
[Left ventricular thrombosis in a case of daunomycin cardiomyopathy].
    Cardiologia (Rome, Italy), 1985, Volume: 30, Issue:2

    Topics: Daunorubicin; Down Syndrome; Echocardiography; Female; Heart Diseases; Heart Ventricles; Humans; Infant; Leukemia, Myeloid, Acute; Thrombosis

1985
Phase II trial of idarubicin in patients with advanced lymphoma.
    Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:3

    Topics: Antibiotics, Antineoplastic; Bone Marrow Diseases; Daunorubicin; Drug Evaluation; Heart Diseases; Humans; Idarubicin; Lymphoma

1988
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia.
    Blood, 1987, Volume: 69, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Resistance; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Prognosis; Thioguanine

1987
[Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Pathologie-biologie, 1987, Volume: 35, Issue:1

    Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Doxorubicin; Heart; Heart Diseases; Heart Failure; Humans; Pericarditis

1987
Specification of regional wall motion abnormalities by phase analysis of radionuclide angiograms in coronary artery disease and non-coronary artery disease patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986, Volume: 27, Issue:6

    Topics: Adult; Aged; Coronary Disease; Daunorubicin; Female; Fourier Analysis; Heart; Heart Diseases; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Radionuclide Imaging

1986
[Ubidecarenone and toxic cardiopathy from antiblastic therapy with daunoblastine].
    Bollettino chimico farmaceutico, 1986, Volume: 125, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Coenzymes; Daunorubicin; Female; Heart Diseases; Humans; Male; Middle Aged; Ubiquinone

1986
Detorubicin--an active anthracycline in untreated metastatic melanoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:11

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Electrocardiography; Female; Heart; Heart Diseases; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Myocardial Contraction; Skin Neoplasms; Stroke Volume; Thrombocytopenia

1985
Editorial: Adriamycin and the heart.
    Lancet (London, England), 1974, Jun-29, Volume: 1, Issue:7870

    Topics: Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Heart; Heart Diseases; Humans; Leukemia; Myocardium

1974
Adriamycin and daunorubicin disposition in the rabbit.
    The Journal of pharmacology and experimental therapeutics, 1974, Volume: 191, Issue:2

    Topics: Adipose Tissue; Animals; Bile; Brain; Chromatography, Thin Layer; Daunorubicin; Doxorubicin; Heart Diseases; Intestine, Small; Kidney; Liver; Lung; Mass Spectrometry; Muscles; Myocardium; Pancreas; Rabbits; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spleen; Time Factors

1974
Daunorubicin and the heart.
    British medical journal, 1974, Nov-23, Volume: 4, Issue:5942

    Topics: Child; Child, Preschool; Daunorubicin; DNA; Dyspnea; Electrocardiography; Heart Diseases; Humans; Hypotension; Tachycardia; Templates, Genetic

1974
[Effect of daunomycin and adriamycin in cytostatic combination therapy of acute leukoses of the adult].
    Medizinische Klinik, 1972, Aug-04, Volume: 67, Issue:31

    Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Blood Coagulation Disorders; Bone Marrow Diseases; Carbenicillin; Cytarabine; Daunorubicin; Drug Synergism; Female; Glycosides; Hair; Heart Diseases; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Remission, Spontaneous; Skin Diseases; Vincristine

1972
High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:6

    Topics: Adult; Child, Preschool; Daunorubicin; Female; Heart Diseases; Humans; Leukemia, Myeloid; Male; Phlebitis; Skin Ulcer

1972
Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).
    Cancer research, 1973, Volume: 33, Issue:12

    Topics: Adolescent; Adult; Age Factors; Aged; Central Nervous System Diseases; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Heart; Heart Diseases; Humans; Infant; Leukemia, Lymphoid; Male; Meninges; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Sex Factors; Time Factors; Vincristine

1973
[Histopathological study of the heart-damaging effects of daunomycin in the chick embryo "in situ". I].
    Quaderni Sclavo di diagnostica clinica e di laboratorio, 1972, Volume: 8, Issue:2

    Topics: Animals; Chick Embryo; Daunorubicin; Female; Fetal Diseases; Fetus; Heart; Heart Diseases; Pregnancy

1972
[Cardiac toxicity of rubidomycin. Apropos of 2 cases].
    Pediatrie, 1973, Volume: 28, Issue:2

    Topics: Child; Daunorubicin; Electrocardiography; Female; Heart; Heart Diseases; Humans; Leukemia

1973
The acute pharmacological actions of daunomycin in the dog and monkey.
    Pharmacology, 1970, Volume: 3, Issue:5

    Topics: Animals; Blood Pressure; Cardiovascular System; Cerebral Ventricles; Coronary Vessels; Daunorubicin; Dogs; Electrocardiography; Electroencephalography; Epinephrine; Haplorhini; Heart Diseases; Heart Rate; Hypoxia; Injections, Intravenous; Muscle Contraction; Norepinephrine; Perfusion; Regional Blood Flow; Respiration; Sympathetic Nervous System

1970